PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVD vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AVD and PFE is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

AVD vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Vanguard Corporation (AVD) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-1.41%
-7.94%
AVD
PFE

Key characteristics

Sharpe Ratio

AVD:

-0.73

PFE:

0.00

Sortino Ratio

AVD:

-0.75

PFE:

0.17

Omega Ratio

AVD:

0.87

PFE:

1.02

Calmar Ratio

AVD:

-0.57

PFE:

0.00

Martin Ratio

AVD:

-1.11

PFE:

0.00

Ulcer Index

AVD:

45.09%

PFE:

9.59%

Daily Std Dev

AVD:

68.84%

PFE:

23.17%

Max Drawdown

AVD:

-87.34%

PFE:

-54.82%

Current Drawdown

AVD:

-83.96%

PFE:

-50.79%

Fundamentals

Market Cap

AVD:

$158.62M

PFE:

$146.72B

EPS

AVD:

-$1.04

PFE:

$1.41

PEG Ratio

AVD:

2.27

PFE:

0.18

Total Revenue (TTM)

AVD:

$381.66M

PFE:

$63.63B

Gross Profit (TTM)

AVD:

$94.20M

PFE:

$41.72B

EBITDA (TTM)

AVD:

-$15.05M

PFE:

$16.34B

Returns By Period

In the year-to-date period, AVD achieves a 19.01% return, which is significantly higher than PFE's -0.80% return. Over the past 10 years, AVD has underperformed PFE with an annualized return of -6.82%, while PFE has yielded a comparatively higher 1.69% annualized return.


AVD

YTD

19.01%

1M

8.46%

6M

-1.43%

1Y

-49.80%

5Y*

-20.14%

10Y*

-6.82%

PFE

YTD

-0.80%

1M

0.07%

6M

-7.93%

1Y

-0.28%

5Y*

-0.95%

10Y*

1.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AVD vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVD
The Risk-Adjusted Performance Rank of AVD is 1313
Overall Rank
The Sharpe Ratio Rank of AVD is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of AVD is 1414
Sortino Ratio Rank
The Omega Ratio Rank of AVD is 1010
Omega Ratio Rank
The Calmar Ratio Rank of AVD is 1313
Calmar Ratio Rank
The Martin Ratio Rank of AVD is 1818
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 4242
Overall Rank
The Sharpe Ratio Rank of PFE is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 3737
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 3636
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 4545
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AVD vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for American Vanguard Corporation (AVD) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AVD, currently valued at -0.73, compared to the broader market-2.000.002.00-0.730.00
The chart of Sortino ratio for AVD, currently valued at -0.75, compared to the broader market-4.00-2.000.002.004.006.00-0.750.17
The chart of Omega ratio for AVD, currently valued at 0.87, compared to the broader market0.501.001.502.000.871.02
The chart of Calmar ratio for AVD, currently valued at -0.57, compared to the broader market0.002.004.006.00-0.570.00
The chart of Martin ratio for AVD, currently valued at -1.11, compared to the broader market0.0010.0020.0030.00-1.110.00
AVD
PFE

The current AVD Sharpe Ratio is -0.73, which is lower than the PFE Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of AVD and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.000.20SeptemberOctoberNovemberDecember2025February
-0.73
0.00
AVD
PFE

Dividends

AVD vs. PFE - Dividend Comparison

AVD's dividend yield for the trailing twelve months is around 1.09%, less than PFE's 6.53% yield.


TTM20242023202220212020201920182017201620152014
AVD
American Vanguard Corporation
1.09%1.30%1.09%0.48%0.49%0.26%0.41%0.53%0.31%0.16%0.14%1.46%
PFE
Pfizer Inc.
6.53%6.33%5.70%3.12%2.64%3.91%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

AVD vs. PFE - Drawdown Comparison

The maximum AVD drawdown since its inception was -87.34%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for AVD and PFE. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%SeptemberOctoberNovemberDecember2025February
-83.96%
-50.79%
AVD
PFE

Volatility

AVD vs. PFE - Volatility Comparison

American Vanguard Corporation (AVD) has a higher volatility of 16.39% compared to Pfizer Inc. (PFE) at 6.49%. This indicates that AVD's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
16.39%
6.49%
AVD
PFE

Financials

AVD vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between American Vanguard Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab